HPI
Exam
Labs
Actions
HPI
Teenager syncopized found to have a prolonged QT
Exam
Labs
Actions
Key Points
Etiology
Drugs
- Complete list at www.QTDrugs.org
- Class Ia antidysrhythmics—quinidine, procainamide, disopyramide
- Class III antidysrhythmics—sotalol, ibutilide, amiodarone
- Antibiotics—erythromycin, pentamidine, chloroquine, trimethoprim–sulfamethoxazole
- Antifungal agents—ketoconazole, itraconazole
- Psychotropic drugs—phenothiazines, haloperidol, risperidone, STCAs
- Cisapride
- Antihistamines
- Organophosphates
- Narcotics—methadone
Electrolyte abnormalities
- Hypokalemia
- Hypomagnesemia
- Hypocalcemia
Cardiac
- Bradyarrhythmias
- Arteriovenous block
- Mitral valve prolapse
- Myocarditis
- Myocardial ischemia
CNS
- Subarachnoid hemorrhage
- Stroke
- Congenital (idiopathic)
Other
- Protein-sparing fasting
- Anorexia nervosa
- Hypothyroidism
- Hypothermia
Management
- Stable patients with prolonged QT transported without intervention
- Cardioversion for unstable patients with confirmed torsades de pointes
- Magnesium sulfate for stable patients with evidence of torsades de pointes
ED TREATMENT/PROCEDURES
- Magnesium sulfate followed by pacing for torsades de pointes.
Magnesium sulfate: 2 g (peds: 25–50 mg/kg) IV bolus over 2–3 min followed by IV infusion at 2–4 mg/min
- Potassium to serum levels of 4.5–5 mEq/L
- Temporary transvenous cardiac pacing (rates from 100–120 beats/min) for recurrences of torsades de pointes refractory to magnesium sulfate therapy (shortens QTc)
- IV isoproterenol for refractory cases or hemodynamically unstable patients with acquired long QT (ineffective in congenital cases) who do not respond to transvenous pacing
Isoproterenol: 1 μg/min (peds: 0.05–0.1 μg/kg/ min) IV continuous infusion, titrate for effect, up to 10 μg/min
- Remove any offending medications and correct metabolic derangements.
- Consult with cardiology in those with symptomatic long QT regarding use of β-blockers at maximum doses.
- Propranolol: 2–3 mg/kg/d (peds: 2–3 mg/kg/d) PO (in consultation with cardiology)
- Pacemaker or defibrillator placement with or without cervicothoracic stellectomy (to reduce adrenergic stimulation) may be required in high-risk patients.
- β-Blockers prevent 70% of cardiac events in congenital cases.
Critical Actions
▢ EKG ordered, look for prolonged QT syndrome
▢ Recognition of torsades after decompensation
▢ Resuscitation per pediatric advanced life support (PALS) guidelines
▢ Cardiology consultation